UNSPSC 51292917: Clomipramine hydrochloride

This classification denotes a tricyclic antidepressant with the molecular formula C19H23ClN2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2LXW0L6GWJ, chemically known as 5h-dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-n,n-dimethyl-, monohydrochloride but more generally known as clomipramine hydrochloride, which bears US NIH Compound Identifier 68539. European Medicines Agency schedules Clomipramine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01361MIG.

UNSPSC 51292917 Clomipramine hydrochloride is a Commodity code that shows minimal relevant recent state and local procurement activity. The single identified opportunity under this code—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems, which fall outside the scope of the antidepressant pharmaceutical named in the code. The mismatch between the code's nominal scope (a tricyclic antidepressant) and the actual procurement (overdose-reversal and drug-disposal equipment) suggests the opportunity was tagged incorrectly or the code does not reflect current state and local pharmaceutical purchasing patterns.

Absent additional recent opportunities properly aligned with clomipramine hydrochloride procurement, this code does not present a clear market signal for business development professionals pursuing pharmaceutical supply contracts with state and local health departments, correctional facilities, or mental-health agencies. Firms specializing in psychiatric pharmaceuticals should monitor state procurement channels and health-department RFQs directly rather than relying on this code's activity.